Author:
Luo Bei,Chen Shuangkou,Guo Yinying,Ren Yuting
Reference17 articles.
1. Wu, C., Zhao, J., Zhou, Z., et al.: Selective PI3K inhibitors research progress. Chin. Pharmacol. 4, 305–310 (2014)
2. Krasilnikov, M.A.: Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Moscow) 65(1), 59–67 (2000)
3. Vogt, P.K., Gymnopoulos, M., Hart, J.R.: PI3K-kinase and cancer: changing accents. Curr. Opin. Genet. Dev. 19(1), 1–17 (2009)
4. Denley, A., Gymnopoulos, M., Kang, S., et al.: Requirement of phosphatidylinositol(3,4,5)trisphosphate (PIP3) in PI3K-induced oncogenic transformation. Mol. Cancer Res. MCR 7(7), 1132 (2009)
5. Uzumcu, M., Westfall, S.D., Dirks, K.A., et al.: Embryonic testis cord formation and mesonephric cell migration requires the phosphotidylinositol 3-kinase signaling pathway. Biol. Reprod. 67(6), 1927–1935 (2002)